SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Peregrine Pharmaceuticals, Inc.( PPHM)
PPHM 4.220+0.7%4:00 PM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Terry D. who started this subject3/30/2004 5:16:29 PM
From: cjgaddy   of 3795
 
If anybody on the Face of the Earth doesn't think TERRYGD exists on another level of Investigational Powers, read these 2 posts, and keep in mind the 2nd on is Terry's from March 16th:

1. ragingbull.lycos.com
By: cjgaddy 3-30-04 RB #138329 of 138380
You could have scanned the AACR Agenda for a week and never have realized that Stephen D. Gillies' (EMD-Lexigen Research Center, Billerica MA) presentation on "Immunocytokine NHS-IL2(D20T)" had anything to do with Epstein and PPHM. Then we see in today's PR announcing the presentation, "TNT directed cytokines are currently under development by Merck KGaA of Darmstadt, Germany under a licensing agreement with Peregrine". It would have taken a Genius to relate that Poster Presentation with Epstein, PPHM, and Merck/Germany. Funny how things are not always as they appear. What else Lurks in the labs of the world? ...Better include "NHS76" with "TNT" searches from now on - that wudda found it.

2. Message 19923885
From: Terry D. MARCH 16, 2004:
"Check this out!!!! Guess who furnished the human anti-DNA antibody. :)"
AACR Abstract #654
"Engineering of an IL-2 immunocytokine with very low toxicity that retains potent anti-tumor activity in immune competent and immune deficient mouse tumor models
Stephen D. Gillies, Yan Lan, Scott Lauder, Beatrice Brunkhorst, Yaping Sun, Kin-Ming Lo. EMD-Lexigen Research Center, Billerica, MA. The use of IL-2 for cancer therapy has been limited" =snip=


= = = = =
Terry, you are Officially a G E N I U S ! ! !

I just shake my head in utter amazement.

If you were 1 in a million, there'd be 4,000 walking around just like you. You are 1 in a billion in my book; now, let's find the other 4.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext